A detailed history of Essex LLC transactions in Novartis Ag stock. As of the latest transaction made, Essex LLC holds 2,450 shares of NVS stock, worth $240,957. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,450
Previous 2,450 -0.0%
Holding current value
$240,957
Previous $260,000 8.08%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$92.57 - $107.37 $9,257 - $10,737
100 Added 4.26%
2,450 $260,000
Q4 2022

Jan 30, 2023

BUY
$75.55 - $92.52 $177,542 - $217,422
2,350 New
2,350 $213,000
Q2 2022

Aug 01, 2022

SELL
$80.52 - $93.75 $189,222 - $220,312
-2,350 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$79.7 - $88.13 $187,295 - $207,105
2,350 New
2,350 $206,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Essex LLC Portfolio

Follow Essex LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex LLC with notifications on news.